Maricla Galetti

2.3k total citations
53 papers, 1.6k citations indexed

About

Maricla Galetti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Maricla Galetti has authored 53 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 30 papers in Oncology and 25 papers in Molecular Biology. Recurrent topics in Maricla Galetti's work include Lung Cancer Treatments and Mutations (19 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and HER2/EGFR in Cancer Research (8 papers). Maricla Galetti is often cited by papers focused on Lung Cancer Treatments and Mutations (19 papers), PI3K/AKT/mTOR signaling in cancer (10 papers) and HER2/EGFR in Cancer Research (8 papers). Maricla Galetti collaborates with scholars based in Italy, United States and Australia. Maricla Galetti's co-authors include Roberta Alfieri, Pier Giorgio Petronini, Andrea Cavazzoni, Claudia Fumarola, Mara Bonelli, Silvia La Monica, Marcello Tiseo, Daniele Cretella, Andrea Ardizzoni and Graziana Digiacomo and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and Blood.

In The Last Decade

Maricla Galetti

52 papers receiving 1.5k citations

Peers

Maricla Galetti

PRM

ONCOL

Chengying Xie China

Silvia La Monica Italy

Tomislav Dragovich United States

Haruhiko Makino Japan

Nehal J. Lakhani United States

G. Veerman Netherlands

Peiwen Yu China

Takayuki Kimura Japan

Sophia Abraham United States

Dongwei Zhang United States

Chengying Xie China

Maricla Galetti

447 ×0.6

PRM

866 ×1.2

ONCOL

777 ×1.2

207 ×1.1

125 ×0.9

Citations per year, relative to Maricla Galetti Maricla Galetti (= 1×) peers Chengying Xie

Countries citing papers authored by Maricla Galetti

Since Specialization

Citations

This map shows the geographic impact of Maricla Galetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maricla Galetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maricla Galetti more than expected).

Fields of papers citing papers by Maricla Galetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maricla Galetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maricla Galetti. The network helps show where Maricla Galetti may publish in the future.

Co-authorship network of co-authors of Maricla Galetti

This figure shows the co-authorship network connecting the top 25 collaborators of Maricla Galetti. A scholar is included among the top collaborators of Maricla Galetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maricla Galetti. Maricla Galetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alfieri, Roberta, Claudia Fumarola, Mara Bonelli, et al.. (2024). Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines. Biochemical Pharmacology. 228. 116161–116161. 4 indexed citations

Monica, Silvia La, Federica Vacondio, Alessio Lodola, et al.. (2024). Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models. Scientific Reports. 14(1). 6491–6491. 5 indexed citations

Volta, Francesco, Silvia La Monica, Alessandro Leonetti, et al.. (2023). Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators. Targeted Oncology. 18(6). 953–964. 8 indexed citations

Adorni, Maria Pia, Maricla Galetti, Silvia La Monica, et al.. (2023). A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC. International Journal of Molecular Sciences. 24(2). 989–989. 8 indexed citations

Galetti, Maricla, Stefano Rossi, Silvana Pinelli, et al.. (2023). Three-Dimensional Bioprinting of Organoid-Based Scaffolds (OBST) for Long-Term Nanoparticle Toxicology Investigation. International Journal of Molecular Sciences. 24(7). 6595–6595. 15 indexed citations

Folesani, Giuseppina, Maricla Galetti, Pier Giorgio Petronini, et al.. (2023). Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review. International Journal of Environmental Research and Public Health. 20(5). 4167–4167. 6 indexed citations

Cavazzoni, Andrea, Graziana Digiacomo, Roberta Alfieri, et al.. (2020). Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers. 12(3). 666–666. 36 indexed citations

Digiacomo, Graziana, Claudia Fumarola, Silvia La Monica, et al.. (2020). Simultaneous Combination of the CDK4/6 Inhibitor Palbociclib With Regorafenib Induces Enhanced Anti-tumor Effects in Hepatocarcinoma Cell Lines. Frontiers in Oncology. 10. 563249–563249. 25 indexed citations

Foresti, Ruben, Stefano Rossi, Silvana Pinelli, et al.. (2019). Highly-defined bioprinting of long-term vascularized scaffolds with Bio-Trap: Complex geometry functionalization and process parameters with computer aided tissue engineering. Materialia. 9. 100560–100560. 20 indexed citations

10.

Monica, Silvia La, Roberta Minari, Daniele Cretella, et al.. (2019). Acquired BRAF G469A Mutation as a Resistance Mechanism to First-Line Osimertinib Treatment in NSCLC Cell Lines Harboring an EGFR Exon 19 Deletion. Targeted Oncology. 14(5). 619–626. 38 indexed citations

11.

Manenti, Lucio, Maria Letizia Urban, Federica Maritati, Maricla Galetti, & Augusto Vaglio. (2017). Complement blockade in ANCA-associated vasculitis: an index case, current concepts and future perspectives. Internal and Emergency Medicine. 12(6). 727–731. 34 indexed citations

12.

Bisceglie, Franco, Rossella Alinovi, Silvana Pinelli, et al.. (2016). Autophagy and apoptosis: studies on the effects of bisthiosemicarbazone copper(ii) complexes on p53 and p53-null tumour cell lines. Metallomics. 8(12). 1255–1265. 21 indexed citations

13.

Bonelli, Mara, Andrea Cavazzoni, Francesca Saccani, et al.. (2015). Inhibition of PI3K Pathway Reduces Invasiveness and Epithelial-to-Mesenchymal Transition in Squamous Lung Cancer Cell Lines Harboring PIK3CA Gene Alterations. Molecular Cancer Therapeutics. 14(8). 1916–1927. 32 indexed citations

14.

Galetti, Maricla, Pier Giorgio Petronini, Claudia Fumarola, et al.. (2015). Effect of ABCG2/BCRP Expression on Efflux and Uptake of Gefitinib in NSCLC Cell Lines. PLoS ONE. 10(11). e0141795–e0141795. 54 indexed citations

15.

Manenti, Lucio, Augusto Vaglio, Umberto Maggiore, et al.. (2015). Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis. Clinical Journal of the American Society of Nephrology. 10(12). 2143–2151. 72 indexed citations

16.

Alfieri, Roberta, Maricla Galetti, Roberta Andreoli, et al.. (2011). Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines. Molecular Cancer. 10(1). 143–143. 37 indexed citations

17.

Bonelli, Mara, Claudia Fumarola, Roberta Alfieri, et al.. (2010). Synergistic activity of letrozole and sorafenib on breast cancer cells. Breast Cancer Research and Treatment. 124(1). 79–88. 32 indexed citations

18.

Galetti, Maricla, Roberta Alfieri, Andrea Cavazzoni, et al.. (2010). Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines. Biochemical Pharmacology. 80(2). 179–187. 29 indexed citations

19.

Bonelli, Mara, Claudia Fumarola, Roberta Alfieri, et al.. (2008). Anti-proliferative effect of combining Letrozole with Sorafenib in MCF-7/Arom-1 breast cancer cells. Cancer Research. 68. 5441–5441. 1 indexed citations

20.

Cavazzoni, Andrea, Maricla Galetti, Claudia Fumarola, et al.. (2006). Effect of inducible FHIT and p53 expression in the Calu-1 lung cancer cell line. Cancer Letters. 246(1-2). 69–81. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact